Aerie Pharma and why biotech investing is terrifying – Business Insider

Google FinanceShares of Aerie Pharmaceuticals erased more than two-thirds of their value in a few minutes late on Thursday.The stock closed nearly 2% higher at $35.39 per share, giving the company a market value of $850 million. Then shortly after the end of trading, the company announced that Rhopressa, an experimental eye drop, failed a late-stage test.In after-hours trading, shares crashed by more […]